comparemela.com

Latest Breaking News On - Neuroscience trading down - Page 1 : comparemela.com

Vigil Neuroscience (NASDAQ:VIGL) Earns Outperform Rating from Wedbush

Vigil Neuroscience (NASDAQ:VIGL) Earns Outperform Rating from Wedbush
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Alto Neuroscience, Inc (NYSE:ANRO) Major Shareholder Purchases $9,600,000 00 in Stock

Alto Neuroscience, Inc (NYSE:ANRO) Major Shareholder Purchases $9,600,000 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Vigil Neuroscience (NASDAQ:VIGL) Stock Price Down 2 5%

Vigil Neuroscience, Inc. (NASDAQ:VIGL – Get Free Report)’s share price traded down 2.5% during trading on Tuesday . The company traded as low as $3.47 and last traded at $3.54. 78,504 shares traded hands during trading, a decline of 70% from the average session volume of 264,717 shares. The stock had previously closed at $3.63. […]

Vigil Neuroscience, Inc (NASDAQ:VIGL) CEO Purchases $15,000 00 in Stock

Vigil Neuroscience, Inc. (NASDAQ:VIGL – Get Free Report) CEO Ivana Magovcevic-Liebisch bought 4,000 shares of the business’s stock in a transaction on Monday, November 20th. The stock was purchased at an average cost of $3.75 per share, with a total value of $15,000.00. Following the purchase, the chief executive officer now owns 207,687 shares of […]

Reunion Neuroscience (TSE:REUN) Trading Down 7 3%

Reunion Neuroscience Inc. (TSE:REUN – Get Rating)’s share price was down 7.3% on Tuesday . The stock traded as low as C$1.01 and last traded at C$1.01. Approximately 5,036 shares traded hands during mid-day trading, a decline of 41% from the average daily volume of 8,492 shares. The stock had previously closed at C$1.09. Analysts […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.